pancreatic cancer semaglutide GLP-1s appear to cut risk. Researchers are asking why and how : NPR GLP-1 Side Effects and Semaglutide:

CEO Brian Niccol explained to Axios in June that the new innovation is geared toward a number of consumer groups, such as 20-year-old males, 50-year-old females and people taking GLP-1s

For patients who have not responded fully to semaglutide or tirzepatide, retatrutide may represent a meaningful step forward

Gradual Tapering of GLP-1 Medications Instead, we recommend working with your doctor to taper off the medication gradually

Toll-like receptor 4 (TLR4) signalling recruits Ly-6Chi macrophages through CCL2/CCR2 interactions, further driving MASLD and MASH progression 40

P., Jordan, R

If one site becomes irritated, skip it entirely until it heals